1. C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. (May 2022) Authors: Klümper, Niklas; Sikic, Danijel; Saal, Jonas; Büttner, Thomas; Goldschmidt, Franziska; Jarczyk, Jonas; Becker, Philippe; Zeuschner, Philip; Weinke, Maximilian; Kalogirou, Charis; Breyer, Johannes; Burger, Maximilian; Nuhn, Philipp; Tully, Karl; Roghmann, Florian; Bolenz, Christian; Zengerling, Fr... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy. Issue 1 (24th May 2020) Authors: Eckstein, Markus; Strissel, Pamela; Strick, Reiner; Weyerer, Veronika; Wirtz, Ralph; Pfannstiel, Carolin; Wullweber, Adrian; Lange, Fabienne; Erben, Philipp; Stoehr, Robert; Bertz, Simone; Geppert, Carol Imanuel; Fuhrich, Nicole; Taubert, Helge; Wach, Sven; Breyer, Johannes; Otto, Wolfgang; Burge... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non‐muscle‐invasive bladder cancer. (9th September 2018) Authors: Breyer, Johannes; Wirtz, Ralph M.; Erben, Philipp; Rinaldetti, Sebastien; Worst, Thomas S.; Stoehr, Robert; Eckstein, Markus; Sikic, Danijel; Denzinger, Stefan; Burger, Maximilian; Hartmann, Arndt; Otto, Wolfgang Journal: BJU international Issue: Volume 123:Number 1(2019) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification and functional characterization of imatinib‐sensitive DTD1‐PDGFRB and CCDC88C‐PDGFRB fusion genes in eosinophilia‐associated myeloid/lymphoid neoplasms. Issue 5 (12th February 2014) Authors: Gosenca, Darko; Kellert, Beate; Metzgeroth, Georgia; Haferlach, Claudia; Fabarius, Alice; Schwaab, Juliana; Kneba, Michael; Scheid, Christof; Töpelt, Karin; Erben, Philipp; Haferlach, Torsten; Cross, Nicholas C. P.; Hofmann, Wolf‐Karsten; Seifarth, Wolfgang; Reiter, Andreas Journal: Genes, chromosomes & cancer Issue: Volume 53:Issue 5(2014:May) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. (January 2019) Authors: Eckstein, Markus; Erben, Philipp; Kriegmair, Maximilian C.; Worst, Thomas S.; Weiß, Cleo-Aron; Wirtz, Ralph M.; Wach, Sven; Stoehr, Robert; Sikic, Danijel; Geppert, Carol I.; Weyerer, Veronika; Bertz, Simone; Breyer, Johannes; Otto, Wolfgang; Keck, Bastian; Burger, Maximilian; Taubert, Helge; Wei... Journal: European journal of cancer Issue: Volume 106(2019) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗